All Type of News
Retail pharmacy complained Boryung's adulterated drug supplies.
The retail pharmacy communities complained Boryung about the sales policy and many adulterated products, saying that many products supplied by Boryung found poor qualities and adulterated. For instance, Maxclan tablet...
Public hearing on separated product and manufacturing business licence
A public hearing on the subject of "Revised pharmaceutical affairs act covering the separated product and business licence" was scheduled to hold at the auditorium of the National Assembly Representative's House at 2:...
Maxmarvil awarded as the 100 outstanding patented products.Maxmarvil, a combined anti-osteoporosis drug developed by Yuyu, was awarded by the Patent Office for an outstanding patented product in the 4th top 100 outstanding patented prod...
|
2 additional cancer centers to establish in 2006.
The MOHW announced on Jan. 11 that two regional cancer centers would be newly established in 2006 for the purpose of minimizing any social costs caused by fatal diseases with an early diagnosis and treatment.
2 can...
Drug industry to put aggressive internet marketing.
Advertising cost saving and more efficient channels for product informations directly to consumers have attracted the drug company to put aggressive marketing activities through the portal sites.
Kwangdong, Boryung...
Abbott to launch RS Virus antibody.Abbott Korea announced to launch Synagis (palivizumab), a monoclonal antibody for the prevention of serious respiratory infection due to respiratory syncytial virus (RSV) infect...
|
Eloxatin liquid form to launch in April.A new liquid injectable form of Eloxatin, which was supplied in a freeze dried powder form of anti colon cancer drug, seems to be launched soon to make ready to administer at ho...
|
Prices for drug ingredients code of 111 to 219 to review.
The MOHW is going to review the drug prices for the drug ingredients with code 111 to 219 for 3 years by an equal number of drugs every year.
The MOHW said that the price review would be applicable to the ingredien...
Handok to forecast 250 BW of sales in 2006.
Handok announced the 2006 sales forecast at 250 billion won, about 7% up from 2005.
Handok made the total 6.4 billion won of investment for the manufacturing facilities, about 77% more than 2005, and planned to lau...
Kwangdong/Finechem trying a joint R&D for new bulk drugs.
Kwangdong agreed with Finechem, a bio venture company of Korea, on Jan. 10 for the local production of new bulk drugs.
Under the agreement, Kwangdong takes responsibilities for the dosage studies, stability tests, ...
